FAP has been shown to promote tumor progression and to be a predictor of poor overall survival for multiple cancer types, including colon cancer, prostate cancer, pancreatic ductal adenocarcinoma, ovarian cancer, and NSCLC [4,8,9,10,11,12,13]. Here, FAP is linked to neoplasm.